Digital Therapeutics Sarcopenia Global Market Report 2025

Description

Digital therapeutics for sarcopenia refer to clinically validated, software-driven interventions designed to prevent, manage, or treat sarcopenia, a condition marked by progressive loss of muscle mass, strength, and functionality. These interventions utilize digital platforms to deliver personalized treatment strategies based on clinical evidence and behavioral science.

The primary products of digital therapeutics for sarcopenia include software, devices, and services. The software delivers tailored interventions such as exercise programs and nutrition plans via digital devices to help users manage muscle loss and support recovery. These solutions are distributed through online platforms, pharmacies, and other channels, with applications including muscle strengthening, physical activity monitoring, and nutrition management. End users include hospitals, clinics, homecare settings, rehabilitation centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The digital therapeutics sarcopenia market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics sarcopenia market statistics, including the digital therapeutics sarcopenia industry global market size, regional shares, competitors with the digital therapeutics sarcopenia market share, detailed digital therapeutics sarcopenia market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics sarcopenia industry. This digital therapeutics sarcopenia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The digital therapeutics sarcopenia market size has grown rapidly in recent years. It will grow from $1.32 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to the increasing aging population, rising prevalence of age-related muscle loss, growing awareness of sarcopenia, expanding adoption of telehealth services, rising demand for home-based rehabilitation solutions, and supportive government initiatives promoting digital healthcare.

The digital therapeutics sarcopenia market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to the rising aging population, increasing focus on preventive muscle health, growing integration of AI in digital therapeutics, expanding reimbursement policies for digital therapeutics (DTx), development of personalized exercise programs, strengthening partnerships between technology firms and healthcare providers, and rising demand for remote rehabilitation solutions. Major trends during this period include advancements in AI-driven personalized exercise programs, integration with wearable health trackers, expansion of tele-rehabilitation platforms, adoption in elderly care, enhanced remote patient monitoring, and innovations in digital health solutions.

The rising prevalence of comorbidities is expected to drive the growth of the digital therapeutics sarcopenia market going forward. Comorbidities refer to the coexistence of two or more health conditions in a single individual. The increase in comorbidities is primarily driven by the aging population, as advancing age raises the risk of developing multiple chronic conditions due to declining physiological functions and prolonged exposure to health risks. Digital therapeutics for sarcopenia are effective in preventing comorbidities, particularly obesity, by encouraging regular physical activity and muscle strengthening, which improve metabolism and reduce fat accumulation. For example, in March 2024, the World Obesity Federation, a UK-based membership organization, reported that nearly 79% of adults affected by overweight and obesity are projected to reside in low- and middle-income nations by 2035, with the total number of adults with obesity expected to reach 1.53 billion. Therefore, the rising prevalence of comorbidities is supporting the growth of the digital therapeutics sarcopenia market.

Key companies in the digital therapeutics sarcopenia market are focusing on developing advanced solutions, such as drug discovery platforms, to create more targeted therapies, improve treatment efficacy, and accelerate personalized care for age-related muscle loss. A drug discovery platform enables faster and more efficient identification and development of new drugs using advanced tools and methods. For instance, in April 2025, ProFuse Technology, an Israel-based biotechnology company, introduced a drug discovery platform aimed at preventing muscle loss caused by GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. By using lab-grown, highly mature muscle tissues that replicate natural muscle, the company can test and screen drug candidates more accurately and efficiently. This innovative platform reduces dependency on animal testing and lowers research costs. With rising demand for muscle-preserving therapies, ProFuse is expanding from cultivated meat into biopharma, offering a pioneering approach to tackle growing muscle health challenges.

In August 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Versanis Bio for $1.9 billion. This acquisition expanded Lilly's portfolio to include Versanis' main asset, bimagrumab, which is currently being evaluated in Phase 2b trials both alone and in combination with semaglutide for individuals with overweight or obesity. Versanis Bio, a US-based pharmaceutical company, specializes in developing therapies for sarcopenia, and this acquisition strengthens Eli Lilly's presence in treatments targeting obesity and muscle loss.

Major players in the digital therapeutics sarcopenia market are Noom Inc., Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Virta Health Corp., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Propeller Health, Lark Technologies Inc., mySugr GmbH, SilverCloud Health Limited (a part of Amwell), Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, and Cometa Srl.

North America was the largest region in the digital therapeutics sarcopenia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics sarcopenia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics sarcopenia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics sarcopenia market consists of revenues earned by entities by providing services such as software-driven therapeutic interventions, integration of predictive analytics, and delivery of rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics sarcopenia market also includes sales of wearable devices, biosensors, and virtual and augmented reality tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Sarcopenia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics sarcopenia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics sarcopenia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics sarcopenia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Software; Devices; Services
2) By Distribution Channel: Online Platforms; Pharmacies; Other Distribution Channels
3) By Application: Muscle Strengthening; Physical Activity Monitoring; Nutrition Management; Other Applications
4) By End User: Hospitals And Clinics; Homecare Settings; Rehabilitation Centers; Other End Users
Subsegments:
1) By Software: Mobile Applications; Web-Based Platforms; AI-Powered Monitoring Tools; Exercise And Rehabilitation Programs; Nutritional Guidance Software
2) By Devices: Wearable Fitness Trackers; Smart Scales; Connected Resistance Bands; Electromyography (EMG) Devices; Muscle Strength Assessment Tools
3) By Services: Remote Patient Monitoring Services; Virtual Physiotherapy Sessions; Teleconsultation Services; Personalized Coaching Services; Data Analytics And Reporting Services
Companies Mentioned: Noom Inc.; Sword Health Inc.; Biofourmis Inc.; Hinge Health Inc.; Omada Health Inc.; Virta Health Corp.; Evolv Rehabilitation Technologies Ltd.; Click Therapeutics Inc.; DarioHealth Corp.; WellDoc Inc.; Propeller Health; Lark Technologies Inc.; mySugr GmbH; SilverCloud Health Limited (a part of Amwell); Kaia Health Software GmbH; Liva Healthcare A/S; Zibrio Inc.; Gait Up SA; Noraxon Inc.; Mira Rehab Limited; Cometa Srl.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37749

1. Executive Summary

2. Digital Therapeutics Sarcopenia Market Characteristics

3. Digital Therapeutics Sarcopenia Market Trends And Strategies

4. Digital Therapeutics Sarcopenia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics Sarcopenia Growth Analysis And Strategic Analysis Framework

5.1. Global Digital Therapeutics Sarcopenia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Digital Therapeutics Sarcopenia Market Growth Rate Analysis
5.4. Global Digital Therapeutics Sarcopenia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Digital Therapeutics Sarcopenia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Digital Therapeutics Sarcopenia Total Addressable Market (TAM)

6. Digital Therapeutics Sarcopenia Market Segmentation

6.1. Global Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Devices
Services
6.2. Global Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Platforms
Pharmacies
Other Distribution Channels
6.3. Global Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Muscle Strengthening
Physical Activity Monitoring
Nutrition Management
Other Applications
6.4. Global Digital Therapeutics Sarcopenia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Homecare Settings
Rehabilitation Centers
Other End Users
6.5. Global Digital Therapeutics Sarcopenia Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mobile Applications
Web-Based Platforms
AI-Powered Monitoring Tools
Exercise And Rehabilitation Programs
Nutritional Guidance Software
6.6. Global Digital Therapeutics Sarcopenia Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wearable Fitness Trackers
Smart Scales
Connected Resistance Bands
Electromyography (EMG) Devices
Muscle Strength Assessment Tools
6.7. Global Digital Therapeutics Sarcopenia Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Remote Patient Monitoring Services
Virtual Physiotherapy Sessions
Teleconsultation Services
Personalized Coaching Services
Data Analytics And Reporting Services

7. Digital Therapeutics Sarcopenia Market Regional And Country Analysis

7.1. Global Digital Therapeutics Sarcopenia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Digital Therapeutics Sarcopenia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics Sarcopenia Market

8.1. Asia-Pacific Digital Therapeutics Sarcopenia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics Sarcopenia Market

9.1. China Digital Therapeutics Sarcopenia Market Overview
9.2. China Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics Sarcopenia Market

10.1. India Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics Sarcopenia Market

11.1. Japan Digital Therapeutics Sarcopenia Market Overview
11.2. Japan Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics Sarcopenia Market

12.1. Australia Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics Sarcopenia Market

13.1. Indonesia Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics Sarcopenia Market

14.1. South Korea Digital Therapeutics Sarcopenia Market Overview
14.2. South Korea Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics Sarcopenia Market

15.1. Western Europe Digital Therapeutics Sarcopenia Market Overview
15.2. Western Europe Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics Sarcopenia Market

16.1. UK Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics Sarcopenia Market

17.1. Germany Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics Sarcopenia Market

18.1. France Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics Sarcopenia Market

19.1. Italy Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics Sarcopenia Market

20.1. Spain Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics Sarcopenia Market

21.1. Eastern Europe Digital Therapeutics Sarcopenia Market Overview
21.2. Eastern Europe Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics Sarcopenia Market

22.1. Russia Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics Sarcopenia Market

23.1. North America Digital Therapeutics Sarcopenia Market Overview
23.2. North America Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics Sarcopenia Market

24.1. USA Digital Therapeutics Sarcopenia Market Overview
24.2. USA Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics Sarcopenia Market

25.1. Canada Digital Therapeutics Sarcopenia Market Overview
25.2. Canada Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics Sarcopenia Market

26.1. South America Digital Therapeutics Sarcopenia Market Overview
26.2. South America Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics Sarcopenia Market

27.1. Brazil Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics Sarcopenia Market

28.1. Middle East Digital Therapeutics Sarcopenia Market Overview
28.2. Middle East Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics Sarcopenia Market

29.1. Africa Digital Therapeutics Sarcopenia Market Overview
29.2. Africa Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics Sarcopenia Market Competitive Landscape And Company Profiles

30.1. Digital Therapeutics Sarcopenia Market Competitive Landscape
30.2. Digital Therapeutics Sarcopenia Market Company Profiles
- 30.2.1. Noom Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sword Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Biofourmis Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Hinge Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics Sarcopenia Market Other Major And Innovative Companies

31.1. Virta Health Corp.
31.2. Evolv Rehabilitation Technologies Ltd.
31.3. Click Therapeutics Inc.
31.4. DarioHealth Corp.
31.5. WellDoc Inc.
31.6. Propeller Health
31.7. Lark Technologies Inc.
31.8. mySugr GmbH
31.9. SilverCloud Health Limited (a part of Amwell)
31.10. Kaia Health Software GmbH
31.11. Liva Healthcare A/S
31.12. Zibrio Inc.
31.13. Gait Up SA
31.14. Noraxon Inc.
31.15. Mira Rehab Limited

32. Global Digital Therapeutics Sarcopenia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Sarcopenia Market

34. Recent Developments In The Digital Therapeutics Sarcopenia Market

35. Digital Therapeutics Sarcopenia Market High Potential Countries, Segments and Strategies

35.1 Digital Therapeutics Sarcopenia Market In 2029 - Countries Offering Most New Opportunities
35.2 Digital Therapeutics Sarcopenia Market In 2029 - Segments Offering Most New Opportunities
35.3 Digital Therapeutics Sarcopenia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer